Comparison of the effects of relaxation and meditation techniques on serum levels of IL-10, TGF-ß, IL-6 and IFN-?

Comparison of the effects of relaxation and meditation techniques on serum levels of IL-10, TGF-ß, IL-6 and IFN-? in the patients with Coronary Artery Disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150519022320N18

Enrollment

Registered

2019-01-27

Start date

2018-12-04

Completion date

Unknown

Last updated

2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerotic heart disease. Chronic ischemic heart disease

Interventions

Intervention 1: Intervention group 1: A relaxation program will be planned and implemented in seven stages for the relaxation group, the steps of which will be:1. Identify the muscles and muscle group

Eligibility

Sex/Gender

All

Age

45 Years to 75 Years

Inclusion criteria

Inclusion criteria: Known coronary artery disease (based on medical records) Background in the CCU Lack of history of mental illness or lack of use of psychoactive drugs Desire to participate in the study Lack of heart failure Lack of autoimmune diseases, allergies and immune-related diseases Age range 45 to 75 years

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Measuring the level of serum IL-6. Timepoint: Before the study and three months after the start of the study. Method of measurement: ELISA test.;Measuring the level of serum IL-10. Timepoint: Before the study and three months after the start of the study. Method of measurement: ELISA test.;Measuring the level of serum TGF-ß. Timepoint: Before the study and three months after the start of the study. Method of measurement: ELISA test.;Measuring the level of serum IFN-?. Timepoint: Before the study and three months after the start of the study. Method of measurement: ELISA test.	—

Measure

Time frame

Measuring the level of serum IL-6. Timepoint: Before the study and three months after the start of the study. Method of measurement: ELISA test.;Measuring the level of serum IL-10. Timepoint: Before the study and three months after the start of the study. Method of measurement: ELISA test.;Measuring the level of serum TGF-ß. Timepoint: Before the study and three months after the start of the study. Method of measurement: ELISA test.;Measuring the level of serum IFN-?. Timepoint: Before the study and three months after the start of the study. Method of measurement: ELISA test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTayebeh mirzaei

Rafsanjan University of Medical Sciences

t.mirzaei@rums.ac.ir+98 34 3452 5900

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026